Release Date: 06/12/13 09:59 Summary: Scheme of Arrangement proceeding dismissed Price Sensitive: Yes Download Document 107.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%